Capital Flow Monitor · Placement agents

Leerink Partners Llc

Firm · None · CRD 39011

Real-estate raises

0

Lodging raises

0

All raises seen

14

Total offered

$1.85B

Licensed / soliciting in: AK AL AR AZ CA CO CT DC DE FL GA HI IL MA MD NC NJ NY OR PA TX WI WV WY

Raises placed

FiledIssuerIndustryRuleOffering% sold
2026-10-02 LISATA THERAPEUTICS, INC. NJ Biotechnology 506(b) $351.9M 100.0%
2026-09-10 Quoin Pharmaceuticals Ltd. VA Pharmaceuticals 506(b) $50.0M 100.0%
2026-09-04 Gossamer Bio, Inc. CA Biotechnology 506(b) $150.0M 16.7%
2026-08-12 Entera Bio Ltd. L3 Biotechnology 506(b) $275.0M 100.0%
2026-05-15 Veradermics, Inc CT Other Health Care 506(b) $30.0M 100.0%
2026-05-04 Climb Bio, Inc. MA Biotechnology 506(b) $110.1M 100.0%
2026-03-25 AN2 Therapeutics, Inc. CA Pharmaceuticals 506(b) $40.0M 100.0%
2026-03-04 IMMUNIC, INC. X1 Biotechnology 506(b) $200.0M 100.0%
2026-01-22 iBio, Inc. CA Biotechnology 506(b) $26.0M 100.0%
2025-11-21 Galecto, Inc. MA Biotechnology 506(b) $285.0M 100.0%
2025-10-17 SPRUCE BIOSCIENCES, INC. CA Biotechnology 506(b) $50.0M 100.0%
2025-09-10 OmniAb, Inc. CA Biotechnology 506(b) $30.0M 100.0%
2025-08-05 SAB Biotherapeutics, Inc. FL Biotechnology 506(b) $175.0M 100.0%
2025-07-18 Ikena Oncology, Inc. MA Biotechnology 506(b) $75.0M 0.0%